Methyl 4-(1-aminocyclopropyl)benzoate hydrochloride → HCID 71204695, compound
Reaction equation
[CH3:1][C@:2]1([C:19]([O-:21])=O)[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[CH2:8][C:9]1[CH:14]=[CH:13][C:12]([C:15]([F:18])([F:17])[F:16])=[CH:11][CH:10]=1.[Li+].Cl.[NH2:24][C:25]1([C:28]2[CH:37]=[CH:36][C:31]([C:32]([O:34][CH3:35])=[O:33])=[CH:30][CH:29]=2)[CH2:27][CH2:26]1>>[CH3:1][C@:2]1([C:19]([NH:24][C:25]2([C:28]3[CH:37]=[CH:36][C:31]([C:32]([O:34][CH3:35])=[O:33])=[CH:30][CH:29]=3)[CH2:27][CH2:26]2)=[O:21])[CH2:7][CH2:6][CH2:5][CH2:4][N:3]1[CH2:8][C:9]1[CH:10]=[CH:11][C:12]([C:15]([F:18])([F:17])[F:16])=[CH:13][CH:14]=1Participants
3
Procedure
The title compound (D157) (5 mg) was prepared according to the general procedure for amides preparation (Method B) starting from lithium (R)-2-methyl-1-(4-(trifluoromethyl)benzyl)piperidine-2-carboxylate (D112) (20 mg) and methyl 4-(1-aminocyclopropyl)benzoate hydrochloride (17.2 mg).
Sources & evidence
- ORD record
- ord-bba698d06194437682c7c184933d3ec2
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181279B2
Reaction notes
Loading…